Keep going, it will get better
    Research/Science 5/24/2025

    At a glance
    In this encouragement and future outlook post, the primary subjects mentioned are
    ๐Ÿ’Š Finasteride (oral) daily
    ๐Ÿ’ง Minoxidil (topical) daily
    the tone is ๐Ÿ˜€ positive.

    Other terms

    Continue using finasteride and minoxidil for hair loss, as better treatments like Breezula, Pyrilutamide, and PP405 are being developed. These future solutions promise fewer side effects and improved results.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 1000+ results

      community July 1st - Early H2 - Breezula

      in Treatment  1 upvotes 8 months ago
      Discussion on hair loss treatments, focusing on Breezula, with mentions of Minoxidil, finasteride, RU58841, Pyrilutamide, GT20029, and PP405. Breezula's effectiveness is uncertain, with some trials showing minimal regrowth.

      community So is this the actual trial results for pp405?????

      in Research/Science  92 upvotes 3 days ago
      PP405 shows promising results for hair growth, potentially outperforming finasteride without side effects like erectile dysfunction. Users discuss using treatments like minoxidil, pyrilutamide, nizoral, and alfatradiol while waiting for PP405's availability.

      community When could we expect pp405 to hit the market?

      in Research/Science  31 upvotes 11 months ago
      PP405 is expected to finish Phase 2 trials in late 2025, with potential market availability around 2028-2029 if all goes well. Current treatments like finasteride and minoxidil are still popular, while new options like KX-826 and Breezula are anticipated soon.

      community Pelage are going to do two phase 3 trials for PP405. How long will it take to complete two phase 3 trials?

      in Chat  45 upvotes 3 months ago
      Pelage plans to conduct two Phase 3 trials for PP405, a new hair loss treatment, which may take about a year to complete. Users discuss various hair loss treatments, including pyrilutamide, minoxidil, finasteride, and clascoterone, with some expressing impatience over the lengthy trial process compared to faster drug approvals like the COVID vaccine.

    Related Research

    6 / 1000+ results